PLoS Neglected Tropical Diseases is devoted to the pathology, epidemiology, treatment, control, and prevention of the NTDs, as well as public policy relevant to this group of diseases.
The NTDs are defined as a group of poverty-promoting chronic infectious diseases, which primarily occur in rural areas and poor urban areas of low-income and middle-income countries. They are poverty-promoting because of their impact on child health and development, pregnancy, and worker productivity, as well as their stigmatizing features.
To see which diseases are included in the journal, please read the detailed scope.
Original Research Papers
Research articles consider all aspects of the NTDs, including their pathogenesis, clinical features, pharmacology and treatment, diagnosis, epidemiology, vector biology, and vaccinology and prevention. Demographic, ecological and social determinants, public health, and policy aspects of these diseases (including cost-effectiveness analyses) are also a priority. PLoS Neglected Tropical Diseases is pleased to publish relevant in vitro and animal studies as well as human investigations. The journal is organized to provide additional support for authors from endemic countries, and such authors are particularly encouraged to submit their research to PLoS Neglected Tropical Diseases. Academic editors, supported by expert peer-reviewers, will select for publication those studies that drive their respective fields forward.
Please refer to our Author Guidelines for instructions on preparing research manuscripts.
The Magazine Section
The Editorial is written by the Editor-in-Chief or a member of the Editorial Board.
The Viewpoint section contains opinion pieces grounded in evidence on topics of broad interest to the journal's readership.
The Debate section highlights controversial issues in the field of NTDs.
The Policy Platform is for authors to discuss policies that could improve the lives of those at risk of, or affected by, the NTDs.
The Reviews section is for authors to summarize the best available evidence on a topic relevant to the NTD community.
In an Expert Commentary, authors discuss the clinical, policy, public-health, or research implications of a freely available research article.
From Innovation to Application is a section in which authors discuss new technologies, including drugs, vaccines, and diagnostics.
In the Symposium section, authors discuss a "real world" problem, from the clinic, laboratory, or community, and how best it can be tackled.
Historical Profiles & Perspectives look back in history to discuss a notable figure or a control program that worked or failed.
Interviews highlight the work of a person who has made a notable contribution to controlling NTDs.
The Public Library of Science (PLoS) applies the Creative Commons Attribution License (CCAL) to all works we publish. Under the CCAL, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in PLoS journals, so long as the original authors and source are cited. No permission is required from the authors or the publishers.